These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 6846162)
1. Acute hemodynamic effects of endralazine: a new vasodilator for chronic refractory congestive heart failure. Quyyumi AA; Wagstaff D; Evans TR Am J Cardiol; 1983 May; 51(8):1353-7. PubMed ID: 6846162 [TBL] [Abstract][Full Text] [Related]
2. Long-term beneficial effects of endralazine, a new arteriolar vasodilator at rest and during exercise capacity in chronic congestive heart failure. Quyyumi AA; Wagstaff D; Evans TR Am J Cardiol; 1984 Nov; 54(8):1020-4. PubMed ID: 6496323 [TBL] [Abstract][Full Text] [Related]
3. Hemodynamic action of nicorandil in chronic congestive heart failure. Solal AC; Jaeger P; Bouthier J; Juliard JM; Dahan M; Gourgon R Am J Cardiol; 1989 Jun; 63(21):44J-48J. PubMed ID: 2525325 [TBL] [Abstract][Full Text] [Related]
4. Clinical evaluation of endralazine (BO22708), a new vasodilator, in essential hypertension. Elliott HL; McLean K; Sumner DJ; Donnelly RJ; Reid JL Clin Exp Hypertens A; 1982; 4(8):1409-18. PubMed ID: 6749347 [TBL] [Abstract][Full Text] [Related]
5. Flosequinan, a new vasodilator: systemic and coronary hemodynamics and neuroendocrine effects in congestive heart failure. Cavero PG; De Marco T; Kwasman M; Lau D; Liu M; Chatterjee K J Am Coll Cardiol; 1992 Dec; 20(7):1542-8. PubMed ID: 1452928 [TBL] [Abstract][Full Text] [Related]
6. Hemodynamic and neurohumoral responses to intravenous nicorandil in congestive heart failure in humans. Giles TD; Pina IL; Quiroz AC; Roffidal L; Zaleski R; Porter RS; Karalis DG; Mohrland JS; Wolf DL; Hearron AE J Cardiovasc Pharmacol; 1992 Oct; 20(4):572-8. PubMed ID: 1280713 [TBL] [Abstract][Full Text] [Related]
7. Combined hemodynamic effects of nifedipine and nitroglycerin in congestive heart failure. Kubo SH; Fox SC; Prida XE; Cody RJ Am Heart J; 1985 Nov; 110(5):1032-4. PubMed ID: 3933315 [TBL] [Abstract][Full Text] [Related]
9. Clinical efficacy of pimobendan (UD-CG 115 BS) in patients with chronic congestive heart failure. Baumann G; Ningel K; Permanetter B J Cardiovasc Pharmacol; 1989; 14 Suppl 2():S23-30. PubMed ID: 2478788 [TBL] [Abstract][Full Text] [Related]
10. Quantitative differences in the hemodynamic effects of captopril and nitroprusside in severe chronic heart failure. Packer M; Meller J; Medina N; Yushak M Am J Cardiol; 1983 Jan; 51(1):183-8. PubMed ID: 6336876 [TBL] [Abstract][Full Text] [Related]
11. Beneficial hemodynamic effects of intravenous diazoxide in refractory congestive heart failure. Massie BM; Stern R; Hanlon JT; Haughom F Am Heart J; 1982 Sep; 104(3):581-6. PubMed ID: 7113899 [TBL] [Abstract][Full Text] [Related]
12. Differences in hemodynamic response to vasodilation due to calcium channel antagonism with nifedipine and direct-acting agonism with hydralazine in chronic refractory congestive heart failure. Elkayam U; Weber L; McKay CR; Rahimtoola SH Am J Cardiol; 1984 Jul; 54(1):126-31. PubMed ID: 6741802 [TBL] [Abstract][Full Text] [Related]
13. Cardiocirculatory effects of afterload reduction with oral trimazosin in severe chronic congestive heart failure. Awan NA; Hermanovich J; Whitcomb C; Skinner P; Mason DT Am J Cardiol; 1979 Jul; 44(1):126-31. PubMed ID: 453037 [TBL] [Abstract][Full Text] [Related]
14. Cinaciguat (BAY 58-2667) improves cardiopulmonary hemodynamics in patients with acute decompensated heart failure. Lapp H; Mitrovic V; Franz N; Heuer H; Buerke M; Wolfertz J; Mueck W; Unger S; Wensing G; Frey R Circulation; 2009 Jun; 119(21):2781-8. PubMed ID: 19451356 [TBL] [Abstract][Full Text] [Related]
15. Acute hemodynamic effect of oral MDL 17,043 in severe congestive heart failure. Uretsky BF; Generalovich T; Reddy PS; Salerni R; Valdes AM; Spangenberg RB; Lang JF; Okerholm RA Am J Cardiol; 1984 Aug; 54(3):357-62. PubMed ID: 6235735 [TBL] [Abstract][Full Text] [Related]
16. Nifedipine in congestive heart failure: effects on resting and exercise hemodynamics and regional blood flow. Leier CV; Patrick TJ; Hermiller J; Pacht KD; Huss P; Magorien RD; Unverferth DV Am Heart J; 1984 Dec; 108(6):1461-8. PubMed ID: 6507242 [TBL] [Abstract][Full Text] [Related]
17. Hemodynamic and hormonal effects of high-dose transdermal nitroglycerin in patients with chronic congestive heart failure. Elkayam U; Roth A; Henriquez B; Weber L; Tonnemacher D; Rahimtoola SH Am J Cardiol; 1985 Sep; 56(8):555-9. PubMed ID: 3929585 [TBL] [Abstract][Full Text] [Related]
18. [Acute hemodynamic effects of pimobendan and captopril: a comparative study in the same patients with chronic heart failure]. Tsuda T; Izumi T; Kodama M; Hanawa H; Ohshima M; Takahashi M; Suzuki M; Aizaki T; Uchiyama H; Shibata A J Cardiol; 1992; 22(4):721-9. PubMed ID: 1343639 [TBL] [Abstract][Full Text] [Related]
19. Hemodynamic assessment of oral peripheral vasodilator therapy in chronic congestive heart failure: prolonged effectiveness of isosorbide dinitrate. Williams DO; Bommer WJ; Miller RR; Amsterdam EA; Mason DT Am J Cardiol; 1977 Jan; 39(1):84-90. PubMed ID: 318795 [TBL] [Abstract][Full Text] [Related]